256 related articles for article (PubMed ID: 10376986)
1. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.
Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y
Br J Cancer; 1999 Jun; 80(8):1289-95. PubMed ID: 10376986
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers.
Hommura F; Dosaka-Akita H; Kinoshita I; Mishina T; Hiroumi H; Ogura S; Katoh H; Kawakami Y
Br J Cancer; 1999 Oct; 81(4):696-701. PubMed ID: 10574258
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
[TBL] [Abstract][Full Text] [Related]
4. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
Kinoshita I; Dosaka-Akita H; Mishina T; Akie K; Nishi M; Hiroumi H; Hommura F; Kawakami Y
Cancer Res; 1996 Dec; 56(24):5557-62. PubMed ID: 8971152
[TBL] [Abstract][Full Text] [Related]
5. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
[TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
Nguyen VN; Mirejovský P; Mirejovský T; Melínová L; Mandys V
Acta Histochem; 2000 Aug; 102(3):323-38. PubMed ID: 10990069
[TBL] [Abstract][Full Text] [Related]
9. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
10. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
[TBL] [Abstract][Full Text] [Related]
11. G1 control gene status is frequently altered in resectable non-small cell lung cancer.
Betticher DC; White GR; Vonlanthen S; Liu X; Kappeler A; Altermatt HJ; Thatcher N; Heighway J
Int J Cancer; 1997 Oct; 74(5):556-62. PubMed ID: 9355981
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II.
Jin M; Inoue S; Umemura T; Moriya J; Arakawa M; Nagashima K; Kato H
Lung Cancer; 2001 Nov; 34(2):207-18. PubMed ID: 11679179
[TBL] [Abstract][Full Text] [Related]
13. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer.
Marchetti A; Doglioni C; Barbareschi M; Buttitta F; Pellegrini S; Gaeta P; La Rocca R; Merlo G; Chella A; Angeletti CA; Dalla Palma P; Bevilacqua G
Int J Cancer; 1998 Jan; 75(2):187-92. PubMed ID: 9462706
[TBL] [Abstract][Full Text] [Related]
16. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
Saitoh G; Sugio K; Ishida T; Sugimachi K
Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
[TBL] [Abstract][Full Text] [Related]
18. Prognostic molecular markers in non-small cell lung cancer.
Nikliński J; Niklińska W; Laudanski J; Chyczewska E; Chyczewski L
Lung Cancer; 2001 Dec; 34 Suppl 2():S53-8. PubMed ID: 11720742
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
20. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]